Access cutting-edge solid tumors treatment through this clinical trial at a research site in Beverly Hills. Study-provided care at no cost to qualified participants.
Access solid tumors specialists in Beverly Hills at no cost
This study follows strict safety protocols and ethical guidelines
All study-related solid tumors treatment provided free
This Phase 1/2a study will explore the safety and efficacy of PTT-936, an Alpha Kinase 1 (ALPK1) activator, used alone or in combination with anti-PD-1/L1 therapy in patients with locally advanced or metastatic solid tumors. The study is divided into two parts: Phase 1 (Part A) focuses on determining the pharmaceutically active dosage range and evaluating the safety profile of PTT-936 when administered as a monotherapy. Phase 2a (Part B) will assess the safety and efficacy of PTT-936 combined wi
Sponsor: Pyrotech Therapeutics, Inc.
Check if you qualify for this solid tumors clinical trial in Beverly Hills, CA
If you're searching for solid tumors treatment options in Beverly Hills, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Beverly Hills research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.